AAREY DRUGS & PHARM LTD (AAREYDRUGS)

NSE: ₹77.33
BSE: ₹78.50
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication

As per Attachment

2026-06-02 18:29:40
Compliances-Reg.24(A)-Annual Secretarial Compliance

As per attachment

2026-05-30 20:19:43
Statement Of Deviation & Variation

as per attachment

2026-05-30 20:18:19
Audited Standalone Financial Results Of The Company For The Fourth Quarter And Year Ended March 31, 2026

As per Attachment

2026-05-30 19:48:24
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 30Th May, 2026

Outcome of Board Meeting held on Saturday, 30th May, 2026

2026-05-30 19:38:55
Board Meeting Intimation for Regarding Postponement And Re-Schedule Of Board Meeting

intimation regarding postponement and re-schedule of Board Meeting which was scheduled to be held on Friday, 29th May, 2026 is postponed and rescheduled on Saturday, 30th May, 2026

2026-05-29 20:14:19
Board Meeting Intimation for Approving The Audited Financial Results For The Quarter And Year Ended March 31, 2026

Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, This is to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 29th May 2026, inter alia, for the following: 1. To consider and approve the Audited Financial Results, along with the Auditors’ Report thereon, of the Company for the quarter and financial year ended March 31, 2026. 2. To Consider any other matter with the permission of chair.

2026-05-25 11:21:15
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018

2026-04-14 18:42:47
Closure of Trading Window

Intimation for closure of trading window

2026-03-26 14:07:58
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication of the Unaudited Financial Results

2026-02-14 15:02:45

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 50.96 57.83 76.48 210.35 126.91 105.14 133.79 108.10 102.21 84.16 96.43 189.47
YOY Revenue Growth % -56.57% -24.17% 22.42% 32.98% 149.06% 81.81% 74.94% -48.61% -19.47% -19.96% -27.93% 75.28%
Other Income 0.70 0.84 0.29 5.14 1.58 0.02 0.68 7.54 1.55 0.79 4.18 -0.43
Total Income 51.65 58.67 76.77 215.49 128.49 105.16 134.47 115.64 103.76 84.95 100.61 189.04
Total Expenses + 50.93 57.66 75.31 213.35 127.16 103.42 133.07 114.01 102.03 83.47 99.68 187.76
Cost of Materials Consumed 43.37 53.36 77.22 213.81 115.09 102.56 131.46 123.75 93.07 78.89 99.30 179.30
Employee Benefit Expense 0.13 0.09 0.20 0.30 0.14 0.22 0.18 0.27 0.14 0.19 0.15 0.29
Other Expenses 1.48 0.72 0.91 5.44 2.00 2.30 1.02 3.51 2.53 0.85 1.00 5.45
Operating Profit 0.03 0.17 1.17 -2.99 -0.24 1.73 0.72 -5.91 0.18 0.69 -3.26 1.71
OPM % 0.1% 0.3% 1.5% -1.4% -0.2% 1.6% 0.5% -5.5% 0.2% 0.8% -3.4% 0.9%
Profit Before Tax + 0.72 1.01 1.47 2.15 1.33 1.75 1.40 1.63 1.73 1.48 0.92 1.28
Tax Expense 0.00 0.22 0.44 -0.01 0.09 0.15 0.68 1.15 0.36 0.46 -0.35 -0.28
Tax % 0% 22.1% 30.2% -0.3% 6.9% 8.6% 48.7% 71.1% 20.6% 30.9% -38.3% -21.7%
Profit After Tax 0.72 0.78 1.02 2.15 1.24 1.60 0.72 0.47 1.37 1.02 1.28 1.56
EPS (Basic) 0.29 0.31 0.40 0.77 0.88 1.14 0.26 0.04 0.48 0.72 0.20 0.55

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 472.27 473.94 395.62 62.47 492.68 348.42
YOY Revenue Growth % -0.35% 19.8% 533.28% -87.32% 41.41% -
Other Income 6.10 9.81 6.96 0.48 2.75 7.01
Total Income 478.37 483.76 402.58 62.95 495.43 355.43
Total Expenses + 472.95 477.65 397.24 62.20 485.40 347.13
Cost of Materials Consumed 450.56 472.87 387.76 60.07 0.00 339.25
Employee Benefit Expense 0.76 0.81 0.72 0.18 4.78 0.40
Other Expenses 9.83 8.83 8.55 2.14 9.35 5.59
Operating Profit -0.68 -3.71 -1.62 0.27 7.28 1.29
OPM % -0.1% -0.8% -0.4% 0.4% 1.5% 0.4%
Profit Before Exceptional 5.41 6.10 5.34 0.75 10.03 8.30
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 5.41 6.10 5.34 0.75 10.03 8.30
Tax Expense 1.45 2.08 0.66 0.25 2.50 1.79
Tax % 26.7% 34.1% 12.3% 33.7% 24.9% 21.5%
Profit After Tax 3.97 4.02 4.68 0.49 7.53 6.51
EPS (Basic) 1.39 3.27 1.84 0.19 2.72 2.79

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 34.30 24.98 206.87 20.72 37.04 0.00
Property, Plant & Equipment 25.78 16.22 14.66 13.94 14.47 0.00
Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00
Non-Current Investments 2.12 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 262.94 213.28 98.12 270.61 208.13 0.00
Inventories 41.54 45.48 34.68 28.82 13.68 0.00
Trade Receivables 129.65 129.61 0.00 189.78 136.28 0.00
Cash and Cash Equivalents 1.40 1.47 1.59 0.71 0.19 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 150.42 138.48 132.77 117.41 113.64 0.00
Equity Share Capital 28.45 28.05 28.05 25.38 25.38 0.00
Other Equity 121.97 110.43 104.72 92.03 88.25 0.00
Non-Current Liabilities 1.75 2.91 3.97 5.78 111.12 0.00
Current Liabilities 145.08 96.88 168.24 168.13 20.41 0.00
Total Liabilities 146.82 99.79 172.22 173.91 131.53 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 10.14 9.65 7.89 -39.09 18.59 8.30
Cash from Investing Activities -12.41 -5.94 -7.32 11.15 24.38 0.00
Cash from Financing Activities 2.20 -3.83 4.10 -22.54 4.38 0.00
Net Increase/Decrease in Cash -0.07 -0.12 4.68 -50.48 46.89 8.30